300676 华大基因
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.1830.9328.27819.19540.890
总资产报酬率 ROA (%)0.1350.6645.60611.48624.442
投入资产回报率 ROIC (%)0.1560.7766.45113.70122.333

边际利润分析
销售毛利率 (%)47.23149.90352.27358.09460.070
营业利润率 (%)1.5193.46315.42426.94129.750
息税前利润/营业总收入 (%)-0.0871.60114.15527.34431.619
净利润/营业总收入 (%)1.0772.15411.47421.84025.033

收益指标分析
经营活动净收益/利润总额(%)332.102206.610115.02096.795104.346
价值变动净收益/利润总额(%)-71.820-28.62638.56014.9056.278
营业外收支净额/利润总额(%)-12.202-30.392-8.057-4.407-2.288

偿债能力分析
流动比率 (X)2.7372.4062.4713.2612.214
速动比率 (X)2.5222.2232.2903.0021.948
资产负债率 (%)23.88426.51128.94533.76446.175
带息债务/全部投入资本 (%)12.58414.78616.16119.847--
股东权益/带息债务 (%)688.884570.761508.284372.023282.188
股东权益/负债合计 (%)314.114273.186242.000193.619114.331
利息保障倍数 (X)0.060-1.518-118.56117.74512.478

营运能力分析
应收账款周转天数 (天)152.866151.33587.48173.8150.000
存货周转天数 (天)109.942109.04185.318119.8260.000